The evolving story of “conditioning” to protect against acute myocardial ischaemia–reperfusion injury

AUTOR(ES)

Hausenloy, Derek J

FONTE

BMJ Group

RESUMO

“… it will not be long before pharmacological therapy, based upon our understanding of the mechanisms of “conditioning”, can be used to protect patients from the consequences of severe acute myocardial ischaemia–reperfusion injury”

Documentos Relacionados

• Bucillamine improves hepatic microcirculation and reduces hepatocellular injury after liver warm ischaemia-reperfusion injury
• Effects of Human Umbilical Cord Mesenchymal Stem Cells on Renal Ischaemia-reperfusion Injury in Rats
• p53 independent induction of PUMA mediates intestinal apoptosis in response to ischaemia–reperfusion
• Effect of allopurinol on the kidney function, histology and injury biomarker (NGAL, IL 18) levels in uninephrectomised rats subjected to ischaemia-reperfusion injury
• Cardioprotection of Rosuvastatin Pre-conditioning on Myocardial Ischemia